Study of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or Hypervolemic Hyponatremia

NCT00492037 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyponatremia

Interventions

DRUG: YM087 oral

Sponsor

Cumberland Pharmaceuticals

Collaborators

[object Object]